Healthcare Services

Hepatic Encephalopathy Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Hepatic Encephalopathy Market From 2026 To 2030?

The hepatic encephalopathy market size has shown substantial growth over recent years. It is anticipated to expand from $1.8 billion in 2025 to $1.89 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.0%. In the past, this growth was primarily due to the increasing prevalence of chronic liver diseases, rising rates of alcohol consumption, a higher incidence of cirrhosis, enhanced diagnostic awareness, and the establishment of more specialty liver care centers.

The market for hepatic encephalopathy is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $2.38 billion, demonstrating a compound annual growth rate (CAGR) of 6.0%. This projected growth during the forecast period is fueled by several factors, including an escalating demand for advanced therapeutic options, a rise in liver transplant procedures, an increased emphasis on lowering hospitalization rates, the broadening of digital monitoring tools, and enhanced investments in hepatology research. Key trends expected in the same period involve a greater uptake of targeted drug therapies, an expanding application of combination treatment regimens, a heightened focus on early diagnosis and continuous monitoring, the development of hospital-based treatment protocols, and improved patient-centric care strategies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12906&type=smp

What Key Drivers Are Influencing The Growth Of The Hepatic Encephalopathy Market?

The expanding occurrence of liver ailments is anticipated to fuel the expansion of the hepatic encephalopathy market. Liver disease, a medical condition, impacts the liver and hinders its proper functioning. Therapies for liver conditions, including hepatic encephalopathy, can ease symptoms, decelerate the disease’s advancement, enhance liver performance, and diminish instances of hepatic encephalopathy. This is achieved by improving the handling of underlying health issues, potentially lessening their frequency and intensity, and elevating patients’ general quality of life. An example of this trend is observed in data from April 2024, where the Office for Health Improvement and Disparities, a UK government department, reported a continued rise in hospital admissions for liver disease. These rates reached 155.2 per 100,000 population (ranging from 152.9 to 157.5) in the financial year ending 2023, an increase from 150.6 (148.2 to 152.9) recorded in the prior year. Consequently, the rising incidence of liver diseases is a key driver for the hepatic encephalopathy market.

Which Segments Are Included In The Analysis Of The Hepatic Encephalopathy Market?

The hepatic encephalopathy market covered in this report is segmented –

1) By Drug Class: Antibiotics, Laxatives

2) By Route Of Administration: Oral, Intravenous, Rectal

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies

Subsegments:

1) By Antibiotics: Rifaximin, Neomycin

2) By Laxatives: Lactulose, Polyethylene Glycol

How Are Trends Transforming The Hepatic Encephalopathy Market Landscape?

Leading companies within the hepatic encephalopathy market are actively developing innovative drugs for hepatic encephalopathy, seeking to achieve competitive advantages and solidify their market standing. For example, in June 2023, Karolinska Development AB, a pharmaceutical company based in Sweden, introduced the novel GR3027 (golexanolone) for treating hepatic encephalopathy. This orally administered small molecule, a GABAA-receptor-modulating steroid antagonist (GAMSA), is designed to antagonize the positive GABAA-receptor modulation by endogenous neuroactive steroids. The drug is also being investigated for HE, with its trial for CHE currently underway in Phases I/IIa.

Which Key Industry Participants Are Active In The Hepatic Encephalopathy Market?

Major companies operating in the hepatic encephalopathy market are Salix Pharmaceuticals, Bausch Health Companies, Norgine, Lupin, Sun Pharmaceutical Industries, Dr Reddys Laboratories, Cipla, Teva Pharmaceutical Industries, Mylan, Torrent Pharmaceuticals, Amneal Pharmaceuticals, Zydus Lifesciences, Aurobindo Pharma, Intas Pharmaceuticals, Alkem Laboratories, Alembic Pharmaceuticals, Wockhardt, Hetero Drugs, Cadila Pharmaceuticals, Abbott India

Read the full hepatic encephalopathy market report here:

https://www.thebusinessresearchcompany.com/report/hepatic-encephalopathy-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Hepatic Encephalopathy Market?

North America was the largest region in the hepatic encephalopathy market in 2025. The regions covered in the hepatic encephalopathy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hepatic Encephalopathy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12906&type=smp

Browse Through More Reports Similar to the Global Hepatic Encephalopathy Market 2026, By The Business Research Company

Encephalitis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report

Liver Diseases Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795